ISALY SAMUEL D
Insider CIK 1055949 · AMBI 10% owner · GKOS Director, 10% owner · ICPT Director, 10% owner · XLRN · DNAI Director · ANTH Director · CCXI 10% owner · SUPN Director, 10% owner · GNOM 10% owner · PCRX 10% owner · RLYP 10% owner · NONE Director, 10% owner · SELB Director, 10% owner · ROKA Director, 10% owner · KALA 10% owner · OTIC Director, 10% owner · ASNS 10% owner · SIEN 10% owner · MRTX 10% owner · LOXO Director, 10% owner · PIRS Director, 10% owner · DMTX Director, 10% owner · VRAY Director, 10% owner · SCPH 10% owner · STDY 10% owner · ADAP Director · ALPN Director, 10% owner · CRVS Director, 10% owner · BOLD 10% owner · AGLE 10% owner · RYTM 10% owner · NTLA Director · RBM Director, 10% owner · CTIC 10% owner · AMRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2018-01-12 | 2018-01-12 | 28,446 | $15.40 | $438.1K | 2,692,715 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2018-01-11 | 2018-01-12 | 41,700 | $13.65 | $569.2K | 2,664,269 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2018-01-10 | 2018-01-12 | 170,338 | $12.83 | $2.19M | 2,622,569 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | S Sale | 2018-01-03 | 2018-01-04 | 1,693,492 | $7.35 | $12.45M | 5,500,730 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | S Sale | 2018-01-03 | 2018-01-04 | 16,128 | $7.35 | $118.5K | 49,270 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 259 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 27,241 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 97 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 10,180 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 83 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 19,811 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 189 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 8,097 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 77 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 9,642 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 92 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 10,182 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 97 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 5,227 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 50 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 6,654 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 63 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 8,717 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 47 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 4,971 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 99 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 10,447 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 97 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 10,216 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 142 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise deriv | 2017-12-18 | 2017-12-20 | 14,858 | — | $0 | 0 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 10,180 | $1.62 | $16.5K | 7,252,241 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 83 | $1.94 | $161 | 65,853 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 8,717 | $1.94 | $16.9K | 7,242,061 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | S Sale | 2017-12-18 | 2017-12-20 | 1,392 | $5.70 | $7.9K | 65,398 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 63 | $2.62 | $165 | 65,770 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 6,654 | $2.62 | $17.4K | 7,233,344 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 50 | $3.00 | $150 | 65,707 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 5,227 | $3.00 | $15.7K | 7,226,690 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 259 | $2.00 | $518 | 65,657 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 27,241 | $2.00 | $54.5K | 7,221,463 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | S Sale | 2017-12-18 | 2017-12-20 | 146,243 | $5.70 | $833.6K | 7,194,222 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 47 | $5.64 | $265 | 66,790 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 4,971 | $5.64 | $28.0K | 7,340,465 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 99 | $2.32 | $230 | 66,743 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 10,447 | $2.32 | $24.2K | 7,335,494 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 97 | $2.01 | $195 | 66,644 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 10,216 | $2.01 | $20.5K | 7,325,047 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 142 | $2.01 | $285 | 66,547 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 14,858 | $2.01 | $29.9K | 7,314,831 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 97 | $1.64 | $159 | 66,405 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 10,182 | $1.64 | $16.7K | 7,299,973 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 92 | $1.73 | $159 | 66,308 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 9,642 | $1.73 | $16.7K | 7,289,791 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 77 | $2.05 | $158 | 66,216 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 8,097 | $2.05 | $16.6K | 7,280,149 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 189 | $1.59 | $301 | 66,139 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 19,811 | $1.59 | $31.5K | 7,272,052 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | M Exercise | 2017-12-18 | 2017-12-20 | 97 | $1.62 | $157 | 65,950 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-12-08 | 2017-12-12 | 250,000 | $82.50 | $20.63M | 941,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-22 | 2017-11-27 | 267,000 | $75.00 | $20.02M | 1,191,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion deriv | 2017-11-21 | 2017-11-21 | 18,500,000 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | C Conversion | 2017-11-21 | 2017-11-21 | 2,576,532 | — | $0 | 2,576,532 | SEC↗ |
| SCPH scPharmaceuticals Inc. | P Buy | 2017-11-21 | 2017-11-21 | 833,333 | $14.00 | $11.67M | 3,409,865 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 2,232,014 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 736,648 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 704,846 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 66,667 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 229,412 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 328,909 | — | $0 | 600,672 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 500,000 | $10.00 | $5.00M | 1,868,966 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 19,533 | — | $0 | 19,533 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 252,230 | — | $0 | 271,763 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 114,320 | — | $0 | 714,992 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 653,974 | — | $0 | 1,368,966 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 100,045 | $74.49 | $7.45M | 1,537,975 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 71,598 | $75.37 | $5.40M | 1,466,377 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 8,377 | $76.23 | $638.6K | 1,458,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 43,300 | $73.48 | $3.18M | 1,638,020 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 46,680 | $72.46 | $3.38M | 1,681,320 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,546,295 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 355,000 | $17.00 | $6.04M | 2,901,295 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 2,546,295 | — | $0 | 2,546,295 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-10-03 | 2017-10-05 | 1,899 | $0.68 | $1.3K | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-10-03 | 2017-10-05 | 199,718 | $0.68 | $135.8K | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-29 | 2017-10-02 | 93,246 | $0.74 | $69.0K | 199,718 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-29 | 2017-10-02 | 888 | $0.74 | $657 | 1,899 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-29 | 2017-09-29 | 672,000 | $28.25 | $18.98M | 4,129,638 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-28 | 2017-10-02 | 376,950 | $0.72 | $271.4K | 292,964 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-28 | 2017-10-02 | 3,592 | $0.72 | $2.6K | 2,787 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-27 | 2017-09-28 | 498 | $0.92 | $458 | 6,379 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-27 | 2017-09-28 | 52,301 | $0.92 | $48.1K | 669,914 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-26 | 2017-09-28 | 74,096 | $1.03 | $76.3K | 722,215 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-09-26 | 2017-09-28 | 706 | $1.03 | $727 | 6,877 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | X Exercise deriv | 2017-09-07 | 2017-09-11 | 5,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | X Exercise | 2017-09-07 | 2017-09-11 | 5,000 | $15.03 | $75.2K | 4,806,638 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | S Sale | 2017-09-07 | 2017-09-11 | 5,000 | $22.35 | $111.8K | 4,801,638 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 173,349 | $37.94 | $6.58M | 1,076,444 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 1,651 | $37.94 | $62.6K | 10,256 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 1,808 | $39.63 | $71.7K | 8,448 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 58,047 | $40.77 | $2.37M | 828,605 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 553 | $40.77 | $22.5K | 7,895 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-05 | 2017-09-05 | 189,792 | $39.63 | $7.52M | 886,652 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-01 | 2017-09-05 | 109,040 | $37.72 | $4.11M | 1,249,793 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-09-01 | 2017-09-05 | 1,038 | $37.72 | $39.2K | 11,907 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-31 | 2017-09-05 | 44,498 | $37.82 | $1.68M | 1,358,833 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-31 | 2017-09-05 | 424 | $37.82 | $16.0K | 12,945 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-24 | 2017-08-25 | 125 | $1.50 | $188 | 7,583 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-24 | 2017-08-25 | 13,075 | $1.50 | $19.6K | 796,311 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-23 | 2017-08-25 | 10 | $1.50 | $15 | 7,708 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-23 | 2017-08-25 | 1,090 | $1.50 | $1.6K | 809,386 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-22 | 2017-08-22 | 52 | $1.52 | $79 | 7,718 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-22 | 2017-08-22 | 5,448 | $1.52 | $8.3K | 810,476 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-21 | 2017-08-22 | 28 | $1.49 | $42 | 7,770 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-21 | 2017-08-22 | 2,952 | $1.49 | $4.4K | 815,924 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-18 | 2017-08-22 | 66,166 | $1.52 | $100.6K | 818,876 | SEC↗ |
| ROKA Roka BioScience, Inc. | S Sale | 2017-08-18 | 2017-08-22 | 630 | $1.52 | $958 | 7,798 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-17 | 2017-08-17 | 224,780 | $37.85 | $8.51M | 1,403,331 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-17 | 2017-08-17 | 2,140 | $37.85 | $81.0K | 13,369 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-16 | 2017-08-17 | 619 | $38.01 | $23.5K | 15,509 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-16 | 2017-08-17 | 64,961 | $38.01 | $2.47M | 1,628,111 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-15 | 2017-08-17 | 307 | $38.29 | $11.8K | 16,128 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-08-15 | 2017-08-17 | 32,193 | $38.29 | $1.23M | 1,693,072 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-27 | 10,707,985 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion | 2017-07-25 | 2017-07-27 | 2,055,946 | — | $0 | 2,055,946 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2017-07-25 | 2017-07-27 | 319,333 | $15.00 | $4.79M | 2,375,279 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award | 2017-07-24 | 2017-07-26 | 3,298,516 | — | $0 | 3,298,516 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion deriv | 2017-06-13 | 2017-06-15 | 7,500 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion | 2017-06-13 | 2017-06-15 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy deriv | 2017-04-25 | 2017-04-27 | 293,500 | $0.13 | $38.2K | 293,500 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy deriv | 2017-04-25 | 2017-04-27 | 293,500 | $0.13 | $38.2K | 293,500 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy | 2017-04-25 | 2017-04-27 | 587,000 | $5.90 | $3.46M | 2,123,098 | SEC↗ |
| STDY SteadyMed Ltd. | P Buy | 2017-04-25 | 2017-04-27 | 587,000 | $5.90 | $3.46M | 2,123,098 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2017-03-27 | 2017-03-28 | 1,190,476 | $4.20 | $5.00M | 6,149,377 | SEC↗ |
| NONE Aerpio Pharmaceuticals, In | P Buy | 2017-03-15 | 2017-03-17 | 762,995 | $5.00 | $3.81M | 4,416,446 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-14 | 2017-03-14 | 73,401 | $44.54 | $3.27M | 1,725,265 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-14 | 2017-03-14 | 699 | $44.54 | $31.1K | 16,435 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 7 | $46.13 | $323 | 17,134 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 693 | $46.13 | $32.0K | 1,798,666 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 1,998 | $45.30 | $90.5K | 17,141 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-13 | 2017-03-14 | 208,712 | $45.30 | $9.45M | 1,799,359 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-10 | 2017-03-14 | 915 | $45.98 | $42.1K | 19,129 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-10 | 2017-03-14 | 96,113 | $45.98 | $4.42M | 2,008,071 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-03 | 2017-03-07 | 55,246 | $47.05 | $2.60M | 2,104,184 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2017-03-03 | 2017-03-07 | 526 | $47.05 | $24.7K | 20,044 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-02-21 | 2017-02-21 | 7,000 | $5.36 | $37.5K | 1,469,524 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-02-17 | 2017-02-21 | 71,800 | $5.19 | $372.6K | 1,462,524 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-02-16 | 2017-02-21 | 30,500 | $5.04 | $153.7K | 1,390,724 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2017-01-18 | 2017-01-20 | 623 | $0.13 | $81 | 3,843 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2017-01-18 | 2017-01-20 | 65,491 | $0.13 | $8.5K | 403,692 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2017-01-18 | 2017-01-20 | 3,118 | $3.00 | $9.4K | 89,225 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2017-01-18 | 2017-01-20 | 327,459 | $3.00 | $982.4K | 9,369,342 | SEC↗ |
| RBM RESPONSE BIOMEDICAL CORP | J Other | 2016-11-29 | 2016-12-01 | 3,604,266 | — | $0 | 0 | SEC↗ |
| RBM RESPONSE BIOMEDICAL CORP | J Other | 2016-11-29 | 2016-12-01 | 2,149,902 | — | $0 | 0 | SEC↗ |
| RBM RESPONSE BIOMEDICAL CORP | J Other | 2016-11-29 | 2016-12-01 | 34,291 | — | $0 | 0 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 3,962 | — | $0 | 3,962 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 38 | — | $0 | 38 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 5,660,377 | — | $0 | 5,660,377 | SEC↗ |
| ROKA Roka BioScience, Inc. | P Buy deriv | 2016-09-21 | 2016-09-23 | 53,909 | — | $0 | 53,909 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2016-08-22 | 2016-08-24 | 3,220 | $0.13 | $419 | 3,220 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy deriv | 2016-08-22 | 2016-08-24 | 338,201 | $0.13 | $44.0K | 338,201 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2016-08-22 | 2016-08-24 | 1,127,338 | $2.95 | $3.33M | 9,041,883 | SEC↗ |
| VRAY ViewRay, Inc. | P Buy | 2016-08-22 | 2016-08-24 | 10,736 | $2.95 | $31.7K | 86,107 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-12 | 2016-08-12 | 133 | $33.72 | $4.5K | 20,570 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-12 | 2016-08-12 | 13,967 | $33.72 | $471.0K | 2,159,430 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-11 | 2016-08-12 | 159,382 | $33.63 | $5.36M | 2,173,397 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-11 | 2016-08-12 | 1,518 | $33.63 | $51.1K | 20,703 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2016-08-10 | 2016-08-12 | 447,857 | $26.96 | $12.07M | 1,728,000 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-10 | 2016-08-12 | 116,825 | $33.77 | $3.95M | 2,332,779 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-10 | 2016-08-12 | 1,113 | $33.77 | $37.6K | 22,221 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-03 | 2016-08-05 | 4,010 | $30.59 | $122.7K | 23,334 | SEC↗ |
| GKOS GLAUKOS Corp | S Sale | 2016-08-03 | 2016-08-05 | 420,990 | $30.59 | $12.88M | 2,449,604 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2016-07-25 | 2016-07-26 | 343,600 | $31.98 | $10.99M | 3,356,400 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2016-07-22 | 2016-07-26 | 3,700,000 | $32.00 | $118.40M | 3,700,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 456,870 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 4,351 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 77,697 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 739 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 380,986 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 3,628 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 456,870 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 4,351 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 77,697 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 739 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 380,986 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion deriv | 2016-06-27 | 2016-06-29 | 3,628 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | P Buy | 2016-06-27 | 2016-06-29 | 544,811 | $14.00 | $7.63M | 1,825,415 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | P Buy | 2016-06-27 | 2016-06-29 | 5,189 | $14.00 | $72.6K | 17,382 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 1,166,884 | — | $0 | 1,280,604 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 11,111 | — | $0 | 12,193 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 11,111 | — | $0 | 12,193 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | C Conversion | 2016-06-27 | 2016-06-29 | 1,166,884 | — | $0 | 1,280,604 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | P Buy | 2016-06-27 | 2016-06-29 | 5,189 | $14.00 | $72.6K | 17,382 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | P Buy | 2016-06-27 | 2016-06-29 | 544,811 | $14.00 | $7.63M | 1,825,415 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-24 | 2016-06-27 | 900 | $12.99 | $11.7K | 5,379,349 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-23 | 2016-06-27 | 100 | $12.92 | $1.3K | 5,378,449 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-21 | 2016-06-21 | 26,083 | $12.87 | $335.7K | 5,378,349 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-17 | 2016-06-21 | 12,300 | $12.48 | $153.5K | 5,352,266 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-16 | 2016-06-16 | 5,000 | $12.04 | $60.2K | 5,339,966 | SEC↗ |
| RBM RESPONSE BIOMEDICAL CORP | P Buy | 2016-06-16 | 2016-06-20 | 331,225 | $0.56 | $185.5K | 2,149,902 | SEC↗ |
| RBM RESPONSE BIOMEDICAL CORP | P Buy | 2016-06-16 | 2016-06-20 | 5,294 | $0.56 | $3.0K | 34,291 | SEC↗ |
| RBM RESPONSE BIOMEDICAL CORP | P Buy | 2016-06-16 | 2016-06-20 | 556,339 | $0.56 | $311.5K | 3,604,266 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-15 | 2016-06-16 | 5,000 | $11.94 | $59.7K | 5,334,966 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-14 | 2016-06-16 | 10,000 | $12.71 | $127.1K | 5,329,966 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-10 | 2016-06-13 | 20,000 | $12.98 | $259.6K | 5,319,966 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-09 | 2016-06-13 | 30,000 | $12.95 | $388.5K | 5,299,966 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-24 | 2016-05-25 | 518,400 | $10.48 | $5.43M | 29,753,404 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-23 | 2016-05-25 | 1,191,600 | $10.40 | $12.39M | 29,235,004 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-20 | 2016-05-24 | 4,716 | $13.09 | $61.7K | 5,269,966 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-20 | 2016-05-25 | 2,400 | $10.04 | $24.1K | 28,043,404 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-19 | 2016-05-20 | 61 | $12.75 | $778 | 5,265,250 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-19 | 2016-05-20 | 2,539 | $12.11 | $30.7K | 5,265,189 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-18 | 2016-05-20 | 4,200 | $11.55 | $48.5K | 5,262,650 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-13 | 2,857,143 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-13 | 873,475 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2016-05-11 | 2016-05-13 | 191,466 | $18.00 | $3.45M | 2,603,646 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-13 | 1,847,400 | — | $0 | 1,847,400 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-13 | 564,780 | — | $0 | 2,412,180 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2016-05-11 | 2016-05-13 | 58,534 | $18.00 | $1.05M | 2,662,180 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-23 | 2015-12-23 | 52,058 | $27.54 | $1.43M | 7,400,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-23 | 2015-12-23 | 47,942 | $26.78 | $1.28M | 7,452,058 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-22 | 2015-12-23 | 111,370 | $26.39 | $2.94M | 7,538,630 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-22 | 2015-12-23 | 38,630 | $27.02 | $1.04M | 7,500,000 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-21 | 2015-12-23 | 235,829 | $27.50 | $6.49M | 7,664,171 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-12-21 | 2015-12-23 | 14,171 | $28.39 | $402.3K | 7,650,000 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-30 | 2015-11-30 | 590 | $29.22 | $17.2K | 1,850,094 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-30 | 2015-11-30 | 2,716 | $28.64 | $77.8K | 1,850,684 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-27 | 2015-11-30 | 29,000 | $28.97 | $840.1K | 1,853,400 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-25 | 2015-11-30 | 34,800 | $28.91 | $1.01M | 1,882,400 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-24 | 2015-11-24 | 36,100 | $28.75 | $1.04M | 1,917,200 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-23 | 2015-11-24 | 80,800 | $28.45 | $2.30M | 1,953,300 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-20 | 2015-11-24 | 83,900 | $28.59 | $2.40M | 2,034,100 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-19 | 2015-11-19 | 127,300 | $28.60 | $3.64M | 2,118,000 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-17 | 2015-11-19 | 10,898 | $28.80 | $313.9K | 2,245,500 | SEC↗ |
| OTIC Otonomy, Inc. | S Sale | 2015-11-17 | 2015-11-19 | 200 | $29.09 | $5.8K | 2,245,300 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion deriv | 2015-10-27 | 2015-10-29 | 5,692,874 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion deriv | 2015-10-27 | 2015-10-29 | 9,500,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion | 2015-10-27 | 2015-10-29 | 3,250,085 | — | $0 | 3,250,085 | SEC↗ |
| DMTX Dimension Therapeutics, In | P Buy | 2015-10-27 | 2015-10-29 | 200,000 | $13.00 | $2.60M | 5,397,698 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion | 2015-10-27 | 2015-10-29 | 1,947,613 | — | $0 | 5,197,698 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2015-10-22 | 2015-10-22 | 310,700 | $12.92 | $4.01M | 7,900,000 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2015-10-22 | 2015-10-22 | 189,300 | $11.97 | $2.27M | 7,589,300 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-12 | 2015-10-13 | 2,785 | $5.98 | $16.7K | 17,100 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-12 | 2015-10-13 | 285,106 | $5.98 | $1.70M | 1,767,902 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-09 | 2015-10-09 | 210,668 | $7.03 | $1.48M | 2,053,008 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-09 | 2015-10-09 | 2,041 | $7.03 | $14.3K | 19,885 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-08 | 2015-10-09 | 3,837 | $7.24 | $27.8K | 21,926 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-08 | 2015-10-09 | 396,163 | $7.24 | $2.87M | 2,263,676 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-07 | 2015-10-09 | 53,446 | $7.36 | $393.4K | 2,659,839 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-07 | 2015-10-09 | 454 | $7.36 | $3.3K | 25,763 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-06 | 2015-10-06 | 59 | $7.80 | $460 | 26,217 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-06 | 2015-10-06 | 6,941 | $7.80 | $54.1K | 2,713,285 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-05 | 2015-10-06 | 136,937 | $8.19 | $1.12M | 2,720,226 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-05 | 2015-10-06 | 1,163 | $8.19 | $9.5K | 26,276 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-02 | 2015-10-06 | 403 | $10.34 | $4.2K | 27,439 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-02 | 2015-10-06 | 47,497 | $10.34 | $491.1K | 2,857,163 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-01 | 2015-10-01 | 47,100 | $10.34 | $487.0K | 2,904,660 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-10-01 | 2015-10-01 | 400 | $10.34 | $4.1K | 27,842 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-30 | 2015-10-01 | 43,471 | $10.17 | $442.1K | 2,951,760 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-30 | 2015-10-01 | 369 | $10.17 | $3.8K | 28,242 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-29 | 2015-10-01 | 10,469 | $10.08 | $105.5K | 2,995,231 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-29 | 2015-10-01 | 89 | $10.08 | $897 | 28,611 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-28 | 2015-09-28 | 89 | $10.30 | $917 | 28,700 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-28 | 2015-09-28 | 10,513 | $10.30 | $108.3K | 3,005,700 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-25 | 2015-09-28 | 800 | $10.07 | $8.1K | 29,100 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-25 | 2015-09-28 | 66,489 | $11.07 | $736.0K | 3,016,213 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-25 | 2015-09-28 | 311 | $11.07 | $3.4K | 28,789 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-25 | 2015-09-28 | 64,400 | $10.07 | $648.5K | 3,082,702 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-24 | 2015-09-28 | 6 | $9.78 | $59 | 3,155,254 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-24 | 2015-09-28 | 148 | $11.00 | $1.6K | 29,900 | SEC↗ |
| SIEN Sientra, Inc. | S Sale | 2015-09-24 | 2015-09-28 | 8,152 | $11.00 | $89.7K | 3,147,102 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion deriv | 2015-07-21 | 2015-07-21 | 1,725,790 | — | $0 | 0 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | J Other | 2015-07-21 | 2015-07-21 | 89,159 | $5.22 | $465.4K | 1,814,949 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | P Buy | 2015-07-21 | 2015-07-21 | 175,000 | $17.00 | $2.98M | 1,989,949 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion | 2015-07-21 | 2015-07-21 | 1,725,790 | — | $0 | 1,725,790 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-07-17 | 2015-07-21 | 285 | — | $0 | 1,120,609 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2015-07-06 | 2015-07-08 | 495,283 | $2.75 | $1.36M | 7,194,222 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2015-07-06 | 2015-07-08 | 4,717 | $2.75 | $13.0K | 65,398 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 1,599 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 27,346 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 2,672 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 280,531 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise deriv | 2015-06-30 | 2015-06-30 | 261 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 167,898 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 22,923 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 2,406,441 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 11,623 | $18.00 | $209.2K | 2,870,593 | SEC↗ |
| GKOS GLAUKOS Corp | F Tax w/h | 2015-06-30 | 2015-06-30 | 111 | $18.00 | $2.0K | 27,344 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 261 | — | $0 | 27,455 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 2,854,870 | — | $0 | 2,854,870 | SEC↗ |
| GKOS GLAUKOS Corp | M Exercise | 2015-06-30 | 2015-06-30 | 27,346 | — | $0 | 2,882,216 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 27,194 | — | $0 | 27,194 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-05-18 | 2015-05-20 | 1,457,551 | $34.13 | $49.75M | 7,400,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 6,000 | $292.13 | $1.75M | 1,122,914 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 3,700 | $291.12 | $1.08M | 1,128,914 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 13,974 | $290.02 | $4.05M | 1,132,614 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 15,131 | $289.07 | $4.37M | 1,146,588 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 26,028 | $288.11 | $7.50M | 1,161,719 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 18,041 | $287.16 | $5.18M | 1,187,747 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-03-26 | 2015-03-30 | 7,611 | $286.24 | $2.18M | 1,205,788 | SEC↗ |